Anuh Pharma share price
You have to be logged in to add this to Watchlist.- ₹81.44(-1.87%)February 12, 2026 15:13:55 PM IST
- NSE
- BSE
- Vol : 25.23 K (NSE + BSE)Last 20 day avg : 53.48 K
Anuh Pharma is trading -1.87% lower at Rs 81.44 as compared to its last closing price. Anuh Pharma has been trading in the price range of 82.99 & 81.18. Anuh Pharma has given 1.52% in this year & 2.46% in the last 5 days. Anuh Pharma has TTM P/E ratio 19.29 as compared to the sector P/E of 23.66.The company posted a net profit of 13.45 Crores in its last quarter.Listed peers of Anuh Pharma include Torrent Pharmaceuticals (0.84%), Cipla (-1.50%), Divi's Laboratories (-4.42%).The Mutual Fund holding in Anuh Pharma was at -% in . The MF holding has - from the last quarter. The FII holding in Anuh Pharma was at 0.03% in 16 Jul 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Feb 13, 2026, 01:58 AM UTC
- Debt To EquityHigher than industry0.03The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.81Annual dividends as a percentage of the stock price.
- P/BLower than historical values2.54The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values19.82Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates Fair Valuation1.26The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,091.00 | 0.84 | 1,38,452.47 | - | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,329.55 | -1.50 | 1,07,425.16 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Neutral | 6,188.20 | -4.42 | 1,64,277.26 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,712.75 | 0.12 | 4,11,104.64 | - | 5.77 | 0.92 | 0.50 |
| Dr Reddy's Laboratories | Bullish | 1,275.00 | 0.37 | 1,06,763.38 | 18.63 | 3.14 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-02-06 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-08 | Quarterly Results & Others |
| 2025-05-23 | Audited Results, Dividend & Bonus issue |
| 2025-02-07 | Quarterly Results & Others |
- IndustryBiotechnology & Drugs
- ISININE489G01022
- BSE Code506260
- NSE CodeANUHPHR
Anuh Pharma is trading at 81.44 as on Thu Feb 12 2026 09:43:55. This is -1.87% lower as compared to its previous closing price of 82.99.
The market capitalization of Anuh Pharma is 816.22 Cr as on Thu Feb 12 2026 09:43:55.
The 52 wk high for Anuh Pharma is 115.00 whereas the 52 wk low is 68.00
Anuh Pharma can be analyzed on the following key metrics -
- TTM P/E: 19.29
- Sector P/E: 23.66
- Dividend Yield: 1.84%
- D/E ratio: -
Anuh Pharma reported a net profit of 47.35 Cr in 2025.